Document
IPR2016-01370, No. 2096-130 Exhibit - Ignoffo (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2096-130 Exhibit - Ignoffo (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2084-111 Exhibit - Rheumatoid Arthritis Signs and Symptoms (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2084-111 Exhibit - Rheumatoid Arthritis Signs and Symptoms (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2001-49 Exhibit - Kurnick D et al, Bioavailability of oral vs subcutaneous low dosemethotrexate in patients with Crohn¿¿¿s disease (P.T.A.B. Nov. 10, 2016)
Cite Document
IPR2016-01370, No. 2001-49 Exhibit - Kurnick D et al, Bioavailability of oral vs subcutaneous low dosemethotrexate in patients with Crohn¿¿¿s disease (P.T.A.B. Nov. 10, 2016)
+ More Snippets
Document
IPR2016-01370, No. 2011-59 Exhibit - Declaration of Terri Shoemaker (P.T.A.B. Nov. 10, 2016)
Cite Document
IPR2016-01370, No. 2011-59 Exhibit - Declaration of Terri Shoemaker (P.T.A.B. Nov. 10, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1031-39 Exhibit - Ex 1031 FDA Arthritis Advisory Committee (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1031-39 Exhibit - Ex 1031 FDA Arthritis Advisory Committee (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1034-42 Exhibit - Ex 1034 Schiff Declaration REDACTED (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1034-42 Exhibit - Ex 1034 Schiff Declaration REDACTED (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1041-149 Exhibit - Correspondence Between Counsel for Petition and Patent Owner (P.T.A.B. Sep. 18, 2017)
Cite Document
IPR2016-01370, No. 1041-149 Exhibit - Correspondence Between Counsel for Petition and Patent Owner (P.T.A.B. Sep. 18, 2017)
+ More Snippets
Document
IPR2016-01370, No. 1042-150 Exhibit - Decision of UK High Court (P.T.A.B. Sep. 18, 2017)
Cite Document
IPR2016-01370, No. 1042-150 Exhibit - Decision of UK High Court (P.T.A.B. Sep. 18, 2017)
+ More Snippets
Document
IPR2016-01370, No. 1026-38 Exhibit - Ex 1026 Bigmar (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1026-38 Exhibit - Ex 1026 Bigmar (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1011-11 Exhibit - Ex 1011 Muller Ladner (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1011-11 Exhibit - Ex 1011 Muller Ladner (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 2097-132 Exhibit - Dorr, Antidotes to Vesicant Chemotherapy Extravasations (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2097-132 Exhibit - Dorr, Antidotes to Vesicant Chemotherapy Extravasations (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2095-128 Exhibit - Gaze (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2095-128 Exhibit - Gaze (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2082-108 Exhibit - Psoriasis Treatments with Next Generation Vitamin D Analogs (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2082-108 Exhibit - Psoriasis Treatments with Next Generation Vitamin D Analogs (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2052-142 Exhibit - DiMasi, R and D Costs and Returns to New Drug Development (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2052-142 Exhibit - DiMasi, R and D Costs and Returns to New Drug Development (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2048-138 Exhibit - Rachakonda, Psoriasis Prevalence Among Adults in the United States (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2048-138 Exhibit - Rachakonda, Psoriasis Prevalence Among Adults in the United States (P.T.A.B. Jun. 9, 2017)
+ More Snippets